APA

Xia L., Qiu H., Chen X., Hu P., Guo G., Wang F., Zhou F., He W., Zhang B. & Zhang L. (20120822). Short-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: a report of 12 cases. : Medical oncology (Northwood, London, England).

Chicago

Xia Liang-Ping, Qiu Hui-Juan, Chen Xu-Xian, Hu Pi-Li, Guo Gui-Fang, Wang Fang, Zhou Fei-Fei, He Wen-Zhuo, Zhang Bei and Zhang Li. 20120822. Short-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: a report of 12 cases. : Medical oncology (Northwood, London, England).

Harvard

Xia L., Qiu H., Chen X., Hu P., Guo G., Wang F., Zhou F., He W., Zhang B. and Zhang L. (20120822). Short-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: a report of 12 cases. : Medical oncology (Northwood, London, England).

MLA

Xia Liang-Ping, Qiu Hui-Juan, Chen Xu-Xian, Hu Pi-Li, Guo Gui-Fang, Wang Fang, Zhou Fei-Fei, He Wen-Zhuo, Zhang Bei and Zhang Li. Short-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: a report of 12 cases. : Medical oncology (Northwood, London, England). 20120822.